GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Proteome Sciences PLC (LSE:PRM) » Definitions » EV-to-FCF

Proteome Sciences (LSE:PRM) EV-to-FCF : -11.43 (As of Apr. 04, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Proteome Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Proteome Sciences's Enterprise Value is £24.40 Mil. Proteome Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was £-2.13 Mil. Therefore, Proteome Sciences's EV-to-FCF for today is -11.43.

The historical rank and industry rank for Proteome Sciences's EV-to-FCF or its related term are showing as below:

LSE:PRM' s EV-to-FCF Range Over the Past 10 Years
Min: -629.49   Med: -11.25   Max: 42.05
Current: -11.43

During the past 13 years, the highest EV-to-FCF of Proteome Sciences was 42.05. The lowest was -629.49. And the median was -11.25.

LSE:PRM's EV-to-FCF is ranked worse than
100% of 105 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.44 vs LSE:PRM: -11.43

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-04), Proteome Sciences's stock price is £0.0406. Proteome Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.014. Therefore, Proteome Sciences's PE Ratio (TTM) for today is At Loss.


Proteome Sciences EV-to-FCF Historical Data

The historical data trend for Proteome Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteome Sciences EV-to-FCF Chart

Proteome Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -492.77 12.90 41.47 10.02 -34.57

Proteome Sciences Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 10.02 - -34.57 -

Competitive Comparison of Proteome Sciences's EV-to-FCF

For the Diagnostics & Research subindustry, Proteome Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteome Sciences's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Proteome Sciences's EV-to-FCF falls into.


;
;

Proteome Sciences EV-to-FCF Calculation

Proteome Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=24.397/-2.134
=-11.43

Proteome Sciences's current Enterprise Value is £24.40 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Proteome Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was £-2.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proteome Sciences  (LSE:PRM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Proteome Sciences's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0406/-0.014
=At Loss

Proteome Sciences's share price for today is £0.0406.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Proteome Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.014.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Proteome Sciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Proteome Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteome Sciences Business Description

Traded in Other Exchanges
Address
Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is protein biomarker research and development. provider of contract research services for the identification, validation and application of protein biomarkers. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Other.

Proteome Sciences Headlines

From GuruFocus

Top 5 2nd Quarter Trades of Stanley Capital Management, LLC

By GuruFocus Research GuruFocus Editor 08-16-2022

Q2 2024 Perimeter Solutions SA Earnings Call Transcript

By GuruFocus Research 08-02-2024

Q3 2022 Perimeter Solutions SA Earnings Call Transcript

By GuruFocus Research 02-11-2024

EQUITABLE TRUST CO Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-21-2023

Q4 2021 Perimeter Solutions SA Earnings Call Transcript

By GuruFocus Research 02-11-2024

Q3 2023 Perimeter Solutions SA Earnings Call Transcript

By GuruFocus Research 02-11-2024

Q3 2021 Perimeter Solutions SA Earnings Call Transcript

By GuruFocus Research 02-11-2024